Krka Underlines Message On Entering Biosimilars Arena In Europe

Slovenian Firm Open For Regulatory And Marketing Collaboration

Krka’s management discussed the firm’s latest perception of the European biosimilars market, as it reported financial results for the nine months to 30 September.

Europe (NicoElNino/Alamy Stock Photo)
Krka is weighing up the European biosimilars market • Source: Shutterstock (NicoElNino / Alamy Stock Photo/Alamy Stock Photo)

Krka Group continues to have no plans to develop biosimilars in-house, noting the amount of risk involved for what it perceives as insufficient returns amid an unfavorable payer market, but will target partnered projects to eventually create a portfolio.

“We will cooperate on specific projects on biosimilars with our strategic partners where we can provide an essential role in...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.